Thank you, Jennifer. Good morning, and thank you to everyone for joining us on the call. As seen on Slide 10, total revenue for the first quarter of 2024 of $10.2 million grew by 6% year-over-year and was right in line with our forecast and the guidance we've laid out last quarter. CarbonSmart revenue of approximately $1 million in JDA & Contract research revenue of $4.3 million, both through year-on-year in the first quarter. The CarbonSmart side, sales from our recurring chemicals customers supported this growth. And on the JDA & Contract research side, the performance was driven by several customers and government grants, which are typically multiyear in duration. Biorefining revenue declined year-over-year in the first quarter to $5 million but saw strong contributions from engineering services revenue across projects in both early and advanced stage engineering as well as from start-up services associated with the ArcelorMittal facility in Belgium. Importantly, the decline year-on-year in Biorefining revenue was anticipated and is attributed to the uneven nature of revenues earned in the early development stages of each project, which currently dominates our Biorefining revenue mix. Notably, we expect the composition of our revenue mix will become increasingly smooth and consistent as we continue to add project opportunities and more projects come online, building recurring revenue as a larger percentage of our overall revenue mix. With respect to margins during the quarter, our focus on revenue quality continued during the first quarter, driving gross profit improvement of 87% year-on-year to $3.5 million. This improvement reflects a higher mix of high-margin engineering services work and JDA & Contracts resulting in first quarter gross margins of 34%, up approximately 570 basis points over the full year 2023 gross margin. As mentioned previously, we continue to expect gross margin to be in the mid- to high 20s for the full year 2024. On the expense side, operating expenses declined 14% year-on-year in the first quarter, coming in at $29.6 million, largely reflective of the onetime expenses in the first quarter of 2023 associated with our Go Public transaction. Sequentially, operating expenses increased due to slightly higher personnel expense and research and development and SG&A from reduced bonuses in Q4 2023 and Q1 2024 severance costs associated with the previously announced reorganization. As Jennifer noted, the executive reorganization that we announced last quarter is complete at the newly reorganized functions are exploring and implementing efficiency and accountability improvements throughout the organization. The associated cost savings initiatives are also well underway and on track to deliver the previously estimated full year cost reductions. CapEx spent during the first quarter of 2024 totaled $1.3 million, and we continue to project CapEx for the full year 2024 to be consistent with or below our CapEx for the prior couple of years. Turning to adjusted EBITDA and cash burn for the quarter. As expected, our adjusted EBITDA loss increased quarter-on-quarter in the first quarter to $22.1 million, largely as a result of the lower Q1 revenue and gross profit as compared to the fourth quarter of 2023. Our total cash burn in the quarter was $29.2 million, which was up quarter-over-quarter as a result of the lower revenue and larger adjusted EBITDA loss was also materially impacted by a number of large annual payments, including 2023 incentive compensation, 2024 insurance premiums and others that are expensed throughout the year were paid in Q1. Importantly, we also expected to invoice and receive a multimillion-dollar payment in the quarter associated with one of our non-contracts, but some administrative contracting issues stand the end of the quarter, resulting in a simple delay in this payment. As a result, we do not believe that this burn rate is indicative of our average quarterly burn rate for the full year 2024. Turning to the balance sheet. As of March 31, 2024, we had $92.3 million of cash on hand, including cash, restricted cash and investments. And in the quarter with more than $92 million of cash on hand, we remain confident that we have the financial flexibility to execute our plan and deliver on our primary objectives outlined for the full year 2024. With that said, we're also announcing today the filing with the SEC of a registration statement on Form S-3 that includes a prospectus offering or an at-the-market or ATM issuance of $100 million of the company's common shares. We recently passed the 1-year anniversary of the completion of our business combination and became eligible to do so, we believe that having a universal shelf as on filings good corporate housekeeping, and the ATM provides us with a tool to opportunistically access additional capital, even though we have no plans at present to utilize it. While we believe we have sufficient liquidity to execute on our near-term objectives and obligations. We will also continue to opportunistically and patiently explore other strategic financing alternatives to ensure we are best positioned to achieve our longer-term growth objectives. Pursuing these additional financing options enables us to maximize potential opportunities to computer supplement our financial flexibility as we continue to explore strategic opportunities to accelerate our growth and path to profitability. Looking ahead to the second quarter and the rest of the year, we continue to anticipate a strong quarter-over-quarter revenue ramp with an expected 20% to 40% quarter-over-quarter growth in Q2 and a very strong back half of the year, underscored by the expectation of moving multiple projects into later stages of development and into construction. As Jennifer mentioned earlier, and as outlined on Slide 11, we are reiterating our full year 2024 guidance of $90 million to $105 million in total revenue, with full year growth across all components of the business. And an obviously significant back-end weighted shift to the year as well as negative $65 million to $80 million to $55 million of adjusted EBITDA. We anticipate the Biorefining revenue growth will come from ongoing and new engineering services revenue as well as the sales of equipment packages related to several projects, and we expect to achieve final investment decision and proceed to the construction phase in 2024. Biorefining will also be bolstered in 2024 by the anticipated kickoff of Project SECURE, our DOE-funded project with Technip for the decarbonization of ethylene production and the multiple opportunities that we are working on to address the growing demand for SAF, including the projects we are codeveloping with LanzaJet and the broader need for waste space ethanol as an enabler of alcohol to jet growth globally. Finally, we continue to anticipate moderate year-on-year growth in our CarbonSmart business and our JDA & Contract research business. With that, I will turn the call back over to Jennifer for some closing remarks before we open the call for Q&A. Jennifer?